Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
ClinicalTrials.gov study NCT02977494. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
ClinicalTrials.gov study NCT07297329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05565807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
ClinicalTrials.gov study NCT00002552. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06169215. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse
ClinicalTrials.gov study NCT00546780. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma
ClinicalTrials.gov study NCT02275403. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03266692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
ClinicalTrials.gov study NCT04827563. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01485835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
ClinicalTrials.gov study NCT05776979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma
ClinicalTrials.gov study NCT03711864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)
ClinicalTrials.gov study NCT04349358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06158841. IPD Sharing: YES. Countries: 25. Publications: 0.
ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01481194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04984434. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation
ClinicalTrials.gov study NCT00002787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02579824. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04649073. IPD Sharing: NO. Countries: 1. Publications: 0.
Elranatamab in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06711705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.